Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

TP Therapeutics, INC Add to portfolio


Recent News + Filings   (All items)
Date FiledTypeDescription
06/21/2019 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
05/31/2019 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
05/31/2019 10-Q Quarterly Report for the period ended March 31, 2019
05/16/2019 4 Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Turning Point Therapeutics, Inc.
05/14/2019 4 Machado Patrick (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
05/14/2019 3 Machado Patrick (Director) has filed a Form 3 on Turning Point Therapeutics, Inc.
05/14/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...


Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues21.115.2
            Revenue growth38.2% 
Cost of goods sold25.616.7
Gross profit-4.6-1.5
            Gross margin-21.7%-9.8%
General and administrative4.61.5
EBIT-25.6-16.7
            EBIT margin-121.7%-109.8%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)3,388.63,337.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy